Neuromyelitis optica spectrum disorders (NMOSD) is recognized as a distinct clinical entity from multiple sclerosis (MS) based on the disease-specific serum autoantibody aquaporin-4 (AQP4)-IgG. The gene discussed is AQP4; the disease is myeloid sarcoma.